PharmAust Announces CEO Resignation and New Interim Leader
Company Announcements

PharmAust Announces CEO Resignation and New Interim Leader

Pharmaust Limited (AU:PAA) has released an update.

PharmAust Limited has announced the resignation of CEO Dr. Michael Thurn, who has contributed significantly to the company’s progress in the development of monepantel for MND/ALS, and the appointment of experienced COO John Clark as the interim CEO. Clark brings over two decades of pharmaceutical industry experience to his new role, where he will continue to advance the company’s clinical and commercial goals. This leadership change comes at a pivotal time for PharmAust as they move toward the commercialization of their lead MPL program.

For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskPharmAust Limited Announces Corporate Rebranding
TipRanks Australian Auto-Generated NewsdeskPharmAust Limited Advises Investor Caution
TipRanks Australian Auto-Generated NewsdeskPharmAust’s Promising Strides in ALS Treatment
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App